{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-038583","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.995655+00:00","generated_at":"2026-05-31T01:07:18.673694+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bone Biologics enters ATM equity offering agreement with H.C. Wainwright for up to $1.14M","bullets":["Entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC to sell common stock shares from time to time.","Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $1,143,121.","Commission to Wainwright at 3.0% of gross proceeds; Company to reimburse expenses up to $100,000 plus due diligence fees.","Offering terminates upon sale of $1.14M or termination by either party; Company not obligated to sell any shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-038583","json":"https://secwatch.observer/filing/0001493152-24-038583.json","markdown":"https://secwatch.observer/filing/0001493152-24-038583.md","text":"https://secwatch.observer/filing/0001493152-24-038583.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/0001493152-24-038583-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:07:18.673694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}